{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:02Z","timestamp":1786119122089,"version":"build-2736575974"},"reference-count":304,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1080\/10673220902891836","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T20:08:49Z","timestamp":1239912529000},"page":"120-137","source":"Crossref","is-referenced-by-count":141,"title":["Update on Research and Treatment of Premenstrual Dysphoric Disorder"],"prefix":"10.1097","volume":"17","author":[{"given":"Joanne","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly Ann","family":"Yonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaughn","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jom.0000150209.44312.d1","article-title":"Estimating direct and indirect costs of premenstrual syndrome.","volume":"47","author":"Borenstein","year":"2005","journal-title":"J Occup Environ Med"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archfami.8.2.122","article-title":"Biological, social, and behavioral factors associated with premenstrual syndrome.","volume":"8","author":"Deuster","year":"1999","journal-title":"Arch Fam Med"},{"key":"R3-5-20210129","first-page":"340","article-title":"Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior.","volume":"33","author":"Johnson","year":"1988","journal-title":"J Reprod Med"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2005.01.003","article-title":"Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States.","volume":"134","author":"Meaden","year":"2005","journal-title":"Psychiatry Res"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1479-828X.1979.tb01366.x","article-title":"Menstrual characteristics of 2343 women attending the Shepherd Foundation.","volume":"19","author":"Wood","year":"1979","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0447.2001.00412.x","article-title":"The epidemiology of perimenstrual psychological symptoms.","volume":"104","author":"Angst","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/jwh.2006.0230","article-title":"E, Dean B B, Leifke E, Korner P, Yonkers K A. Differences in symptom scores and health outcomes in premenstrual syndrome.","volume":"16","author":"Borenstein","year":"2007","journal-title":"J Womens Health"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jwh.2007.0417","article-title":"Burden of premenstrual dysphoric disorder on health-related quality of life.","volume":"17","author":"Yang","year":"2008","journal-title":"J Womens Health"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/jwh.1.1999.8.1043","article-title":"The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France.","volume":"8","author":"Hylan","year":"1999","journal-title":"J Womens Health Gend Based Med"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4088\/JCP.v61n0205","article-title":"Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.","volume":"61","author":"Pearlstein","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R13-5-20210129","first-page":"515","article-title":"Health and economic impact of the premenstrual syndrome.","volume":"48","author":"Borenstein","year":"2003","journal-title":"J Reprod Med"},{"key":"R14-5-20210129","first-page":"637","article-title":"Premenstrual symptoms in general practice patients. Prevalence and treatment.","volume":"42","author":"Campbell E M, Peterkin","year":"1997","journal-title":"J Reprod Med"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community.","volume":"32","author":"Wittchen H U, Becker","year":"2002","journal-title":"Psychol Med"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-0327(95)00017-H","article-title":"K, Chandra P S, Gururaj G, Pandian R D, Beena M B. Suicidal ideas during premenstrual phase.","volume":"34","author":"Chaturvedi","year":"1995","journal-title":"J Affect Disord"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00005053-198609000-00002","article-title":"L, Steege J F, Blazer D G, George L K. Comparison of lifetime psychiatric diagnoses in premenstrual syndrome clinic and community samples.","volume":"174","author":"Stout","year":"1986","journal-title":"J Nerv Ment Dis"},{"issue":"suppl 3","key":"R18-5-20210129","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMSPMDD).","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/09513590601167969","article-title":"Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies.","volume":"23","author":"Halbreich","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1176\/ajp.149.4.525","article-title":"W, Schnurr P P, Severino S K, et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints.","volume":"149","author":"Hurt","year":"1992","journal-title":"J Am Psychiatry"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/01674820600747269","article-title":"D. Premenstrual dysphoric disorder: prevalence, diagnostic considerations, and controversies.","volume":"27","author":"Di Giulio","year":"2006","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R23-5-20210129","first-page":"183","article-title":"ACOG Practice Bulletin. Premenstrual syndrome. Number 15, April 2000.","volume":"73","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0193-953X(03)00035-2","article-title":"A biopsychosocial approach to premenstrual dysphoric disorder.","volume":"26","author":"Ross L E, Steiner","year":"2003","journal-title":"Psychiatr Clin North Am"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4088\/JCP.v65n1004","article-title":"Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder.","volume":"65","author":"Perkonigg","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R26-5-20210129","first-page":"403","article-title":"S, Thompson K S, Light K C, Leserman J, Pedersen C A, Prange A J, Jr. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder.","volume":"66","author":"Girdler","year":"2004","journal-title":"Psychosom Med"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2007.05.006","article-title":"Neurosteroids in the context of stress: implications for depressive disorders.","volume":"116","author":"Girdler S S, Klatzkin","year":"2007","journal-title":"Pharmacol Ther"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.biopsycho.2004.08.002","article-title":"L, Light K C, Leserman J, Pedersen C A, Girdler S S. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder.","volume":"69","author":"Bunevicius","year":"2005","journal-title":"Biol Psychol"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/01612840600996281","article-title":"Relationship of adolescent physical and sexual abuse to perimenstrual symptoms (PMS) in adulthood.","volume":"28","author":"Koci","year":"2007","journal-title":"Issues Ment Health Nurs"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily Record of Severity of Problems (DRSP): reliability and validity.","volume":"9","author":"Endicott","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/01.AOG.0000259920.73000.3b","article-title":"E, Dean B B, Yonkers K A, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome.","volume":"109","author":"Borenstein","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R32-5-20210129","first-page":"302","article-title":"F, Girton L, Beck L, Yen S S. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences.","volume":"76","author":"Mortola","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00006842-196811000-00006","article-title":"The development of a menstrual distress questionnaire.","volume":"30","year":"1968","journal-title":"Psychosom Med"},{"key":"R34-5-20210129","first-page":"109","article-title":"Retrospective report of premenstrual depressive changes.","volume":"18","author":"Endicott","year":"1982","journal-title":"Psychopharmacol Bull"},{"key":"R35-5-20210129","first-page":"1","article-title":"Premenstrual syndrome.","volume":"8","author":"Reid","year":"1985","journal-title":"Curr Probl Obstet Gynecol Fertil"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"A, OBrien P MS, Eriksson E. Premenstrual syndrome.","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2105\/AJPH.72.11.1257","article-title":"Prevalence of perimenstrual symptoms.","volume":"72","author":"Woods","year":"1982","journal-title":"J Am Public Health"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/01674828609016741","article-title":"Premenstrual complaints. Prevalence of premenstrual symptoms in a Swedish urban population.","volume":"5","author":"Andersch","year":"1986","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0895-4356(92)90039-P","article-title":"J, Fick G H, Goldfien A. The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women: attributable risk and risk factors.","volume":"45","author":"Ramcharan","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1176\/ajp.147.12.1634","article-title":"Late luteal phase dysphoric disorder in young women.","volume":"147","author":"Rivera-Tovar A D, Frank","year":"1990","journal-title":"J Am Psychiatry"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/152460901753285778","article-title":"N, Cohen L S, Otto M W, Harlow B L. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles.","volume":"10","author":"Soares","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00737-006-0137-9","article-title":"Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women.","volume":"9","author":"Takeda","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jad.2004.10.004","article-title":"Pretreatment pattern of symptom expression in premenstrual dsyphoric disorder.","volume":"85","author":"Pearlstein","year":"2005","journal-title":"J Affect Disord"},{"key":"R44-5-20210129","first-page":"1014","article-title":"Severity of premenstrual symptoms in a health maintenance organization population.","volume":"99","author":"Sternfeld","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1176\/ajp.154.12.1741","article-title":"Premenstrual syndrome: evidence for symptom stability across cycles.","volume":"154","author":"Bloch","year":"1997","journal-title":"J Am Psychiatry"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.162.4.481","article-title":"The premenstrual syndrome: a twin study.","volume":"162","year":"1993","journal-title":"J Br Psychiatry"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1176\/ajp.155.9.1234","article-title":"Longitudinal population-based study of retrospectively reported premenstrual symptoms and lifetime major depression.","volume":"155","author":"Kendler","year":"1998","journal-title":"J Am Psychiatry"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0033291701004901","article-title":"M, Martin N G. Genetic and environmental influences on premenstrual symptoms in an Australian twin sample.","volume":"32","author":"Treloar","year":"2002","journal-title":"Psychol Med"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.AOG.0000284448.73490.ac","article-title":"L, OBrien P M, Chapman G, Fryer A A, Ismail K M. Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder.","volume":"110","author":"Dhingra","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R50-5-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.biopsych.2006.12.019","article-title":"Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.","volume":"62","author":"Huo","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/01443610400023049","article-title":"Obesity as a risk factor for premenstrual syndrome.","volume":"26","author":"Masho S W, Adera","year":"2005","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"suppl 1","key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.neures.2007.06.689","article-title":"Impaired reactivity to mental stress in premenstrual dysphoric disorder PMDD patients.","volume":"58","author":"Nakamoto","year":"2007","journal-title":"Neurosci Res"},{"key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1037\/0278-6133.26.2.201","article-title":"S, Leserman J, Bunevicius R, Klatzkin R, Pedersen C A, Light K C. Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder.","volume":"26","author":"Girdler","year":"2007","journal-title":"Health Psychol"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0140-6736(74)92132-1","article-title":"P. An evolutionary theory of premenstrual tension.","volume":"2","author":"Rosseinsky","year":"1974","journal-title":"Lancet"},{"key":"R55-5-20210129","first-page":"509","article-title":"Aggressive behaviour in oestrus and dioestrus dairy cows and heifers.","volume":"34","author":"Castellanos","year":"1973","journal-title":"J Reprod Fertil"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1037\/h0077341","article-title":"Aggressive behaviour in female hamsters: the hormonal basis for fluctuations in female aggressiveness correlated with estrous state.","volume":"91","author":"Floody","year":"1977","journal-title":"J Comp Physiol Psychol"},{"key":"R57-5-20210129","first-page":"11","article-title":"Changes in the social dynamics associated to the menstrual cycle in the vervet monkey.","volume":"37","author":"Garcia-Castell","year":"1989","journal-title":"Bol Estud Med Biol"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0306-4530(94)00060-N","article-title":"Menstrual cycle and social behavior in vervet monkeys.","volume":"20","author":"Rapkin","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0893-133X(00)00219-0","article-title":"The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability.","volume":"24","author":"Ho","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0018-506X(77)90064-2","article-title":"Estrous cycle fluctuations in aggressiveness of house mice.","volume":"9","author":"Hyde","year":"1977","journal-title":"Horm Behav"},{"key":"R61-5-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yhbeh.2006.09.006","article-title":"Increased depressive-like traits in an animal model of premenstrual irritability.","volume":"51","author":"Schneider","year":"2007","journal-title":"Horm Behav"},{"key":"R62-5-20210129","first-page":"83","article-title":"Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle.","volume":"27","author":"Marvan","year":"1996","journal-title":"Arch Med Res"},{"key":"R63-5-20210129","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pbb.2007.05.017","article-title":"Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility.","volume":"87","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"R64-5-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/edrv-12-4-372","article-title":"Recurrent secretion of progesterone in large amounts: an endocrinemetabolic disorder unique to young women.","volume":"12","author":"MacDonald","year":"1991","journal-title":"Endocr Rev"},{"key":"R65-5-20210129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneurpsyc.1931.02230110151009","article-title":"The hormonal causes of premenstrual tension.","volume":"26","author":"Frank","year":"1931","journal-title":"Arch Neurol Psychiatry"},{"key":"R66-5-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1530\/acta.0.1250132","article-title":"Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome.","volume":"125","author":"Hammarback","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"key":"R67-5-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0002-9378(90)90831-Q","article-title":"The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome.","volume":"162","author":"Casper","year":"1990","journal-title":"J Am Obstet Gynecol"},{"key":"R68-5-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9378(90)90830-Z","article-title":"Lasting response to ovariectomy in severe intractable premenstrual syndrome.","volume":"162","author":"Casson","year":"1990","journal-title":"J Am Obstet Gynecol"},{"key":"R69-5-20210129","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/13697130400012262","article-title":"Hormones and depression in women.","volume":"7","author":"Studd","year":"2004","journal-title":"Climacteric"},{"key":"R70-5-20210129","first-page":"33","article-title":"Estrogens and depression in women.","volume":"1","author":"Studd","year":"1994","journal-title":"Menopause"},{"key":"R71-5-20210129","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/humrep\/deh354","article-title":"H, Vashisht A, Studd J WW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome.","volume":"19","author":"Cronje","year":"2004","journal-title":"Hum Reprod"},{"key":"R72-5-20210129","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM198411223112104","article-title":"The premenstrual syndrome: effects of medical ovariectomy..","volume":"311","author":"Muse","year":"1984","journal-title":"N J Engl Med"},{"key":"R73-5-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2265.1987.tb01142.x","article-title":"The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes.","volume":"27","author":"Bancroft","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R74-5-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00016348809004191","article-title":"Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo.","volume":"67","author":"Hammarback","year":"1988","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R75-5-20210129","first-page":"891","article-title":"Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.","volume":"78","author":"Sundstrom","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R76-5-20210129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without add-back therapy in treating premenstrual syndrome: a meta analysis.","volume":"6","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"key":"R77-5-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainresrev.2005.11.001","article-title":"Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.","volume":"51","author":"Birzniece","year":"2006","journal-title":"Brain Res Rev"},{"key":"R78-5-20210129","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/31948","article-title":"GABA A receptor alpha-4 subunit suppression prevents withdrawal properties of an endogenous steroid.","volume":"392","author":"Smith","year":"1998","journal-title":"Nature"},{"key":"R79-5-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00213-005-0168-3","article-title":"Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha, 5beta-THP: a possible model of premenstrual dysphoric disorder.","volume":"186","author":"Smith","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R80-5-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00737-002-0147-1","article-title":"GABA receptors, progesterone and premenstrual dysphoric disorder.","volume":"6","author":"Sundstrom Poromaa","year":"2003","journal-title":"Arch Womens Ment Health"},{"key":"R81-5-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cne.20540","article-title":"Withdrawal from progesterone increases expression of alpha4, beta1, and delta GABA(A) receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats.","volume":"486","author":"Griffiths","year":"2005","journal-title":"J Comp Neurol"},{"key":"R82-5-20210129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1286.005","article-title":"Pathogenesis in menstrual cycle-linked CNS disorders.","volume":"1007","author":"Backstrom","year":"2003","journal-title":"N Ann Y Acad Sci"},{"key":"R83-5-20210129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steriods in women with and in those without premenstrual syndrome.","volume":"338","author":"Schmidt","year":"1998","journal-title":"N J Engl Med"},{"key":"R84-5-20210129","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.323.7316.776","article-title":"Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review.","volume":"323","author":"Wyatt","year":"2001","journal-title":"BMJ"},{"key":"R85-5-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.mp.4002030","article-title":"Progesterone selectively increases amygdala reactivity in women.","volume":"13","author":"van Wingen","year":"2008","journal-title":"Mol Psychiatry"},{"key":"R86-5-20210129","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1471-0528.1986.tb07868.x","article-title":"The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.","volume":"93","author":"Magos","year":"1986","journal-title":"J Br Obstet Gynaecol"},{"key":"R87-5-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016348509155154","article-title":"Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy.","volume":"64","author":"Hammarback","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R88-5-20210129","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jcem.83.6.4905","article-title":"Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences.","volume":"83","author":"Genazzani A R, Petraglia","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R89-5-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-978871","article-title":"Allopregnanolone in women with premenstrual syndrome.","volume":"30","author":"Bicikova","year":"1998","journal-title":"Horm Metab Res"},{"key":"R90-5-20210129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","article-title":"Progesterone metabolite allopregnanolone in women with premenstrual syndrome.","volume":"90","author":"Rapkin","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R91-5-20210129","first-page":"1256","article-title":"Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.","volume":"79","author":"Schmidt","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R92-5-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0306-4530(96)00035-2","article-title":"Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.","volume":"22","author":"Sundstrom","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"R93-5-20210129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.euroneuro.2006.02.006","article-title":"D, Gartside S E, Young A H, Judge S J. The progesterone metabolite allopregnanolone potentiates GABA(A) receptor-mediated inhibition of 5-HT neuronal activity.","volume":"17","author":"Kaura","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"R94-5-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10253890701200997","article-title":"GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders.","volume":"10","author":"Matsumoto","year":"2007","journal-title":"Stress"},{"key":"R95-5-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2007-1726","article-title":"Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.","volume":"93","author":"Thys-Jacobs","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R96-5-20210129","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199104253241705","article-title":"Lack of effect of induced menses on symptoms in women with premenstrual syndrome.","volume":"324","author":"Schmidt","year":"1991","journal-title":"N J Engl Med"},{"key":"R97-5-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1196\/annals.1347.003","article-title":"Depression, the perimenopause, and estrogen therapy.","volume":"1052","author":"Schmidt","year":"2005","journal-title":"N Ann Y Acad Sci"},{"key":"R98-5-20210129","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1210\/jc.2002-020755","article-title":"Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.","volume":"88","author":"Bjorn","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R99-5-20210129","first-page":"671","article-title":"Thyroid function in women with premenstrual syndrome.","volume":"76","author":"Schmidt","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R100-5-20210129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0306-4530(94)00068-9","article-title":"Thyroid axis function during the menstral cycle in women with premenstrual syndrome.","volume":"20","author":"Girdler","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"R101-5-20210129","first-page":"2280","article-title":"I, Lamont J A, Steiner M. Late luteal phase dysphoric disorder and the thyroid axis revisited.","volume":"81","author":"Korzekwa","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R102-5-20210129","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.nmd.0000244488.17025.0e","article-title":"T, Haaga D A, Rohan K J. The association between seasonal and premenstrual symptoms is continuous and is not fully accounted for by depressive symptoms.","volume":"194","author":"Portella","year":"2006","journal-title":"J Nerv Ment Dis"},{"key":"R103-5-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.2044-8260.1996.tb01174.x","article-title":"Rhythm and blues: the theory and treatment of seasonal affective disorder.","volume":"35","author":"Dalgleish","year":"1996","journal-title":"J Br Clin Psychol"},{"key":"R104-5-20210129","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.1990.01810240059010","article-title":"L, Berga S L, Kripke D F, et al. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression.","volume":"47","author":"Parry","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R106-5-20210129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00737-007-0186-8","article-title":"Stable serum levels of relaxin throughout the menstrual cycle: a preliminary comparison of women with premenstrual dysphoria and controls.","volume":"10","author":"Pehrsson","year":"2007","journal-title":"Arch Womens Ment Health"},{"key":"R107-5-20210129","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1210\/jc.2006-2726","article-title":"Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder.","volume":"92","author":"Thys-Jacobs","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R108-5-20210129","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajog.2007.11.005","article-title":"Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.","volume":"198","author":"Thys-Jacobs","year":"2008","journal-title":"J Am Obstet Gynecol"},{"key":"R109-5-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/000456328602300607","article-title":"Magnesium and the premenstrual syndrome.","volume":"23","author":"Sherwood","year":"1986","journal-title":"Ann Clin Biochem"},{"key":"R110-5-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/01674829009084417","article-title":"Reduction of monocytes magnesium in patients affected by premenstrual syndrome.","volume":"11","author":"Facchinetti","year":"1990","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R111-5-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0006-3223(94)90103-1","article-title":"Magnesium measures across the menstrual cycle in premenstrual syndrome.","volume":"35","author":"Rosenstein","year":"1994","journal-title":"Biol Psychiatry"},{"issue":"suppl 12","key":"R112-5-20210129","first-page":"17","article-title":"Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.","volume":"61","author":"Steiner","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R113-5-20210129","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"R114-5-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.1071829","article-title":"Serotonin transporter genetic variation and the response of the human amygdala.","volume":"297","author":"Hariri","year":"2002","journal-title":"Science"},{"key":"R115-5-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.163.1.52","article-title":"Lower serotonin transporter binding potential in the human brain during major depressive episodes.","volume":"163","author":"Parsey","year":"2006","journal-title":"J Am Psychiatry"},{"issue":"suppl 7","key":"R116-5-20210129","first-page":"16","article-title":"Diagnosis and treatment of premenstrual dysphoria.","volume":"63","author":"Eriksson","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R117-5-20210129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.psyneuen.2007.04.003","article-title":"Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants.","volume":"32","author":"Schneider","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"R118-5-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0278-5846(88)90061-9","article-title":"A regional study of sex differences in rat brain serotonin.","volume":"12","author":"Carlsson","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R119-5-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.biopsych.2005.10.019","article-title":"Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field.","volume":"60","author":"Hiroi","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R120-5-20210129","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0006-3223(98)00162-0","article-title":"Estrogen-serotonin interactions: implications for affective regulation.","volume":"44","author":"Rubinow","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R121-5-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0306-4522(99)00234-1","article-title":"Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone.","volume":"94","author":"Zhang","year":"1999","journal-title":"Neuroscience"},{"key":"R122-5-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/frne.2001.0225","article-title":"Diverse actions of ovarian steroids in the serotonin neural system.","volume":"23","author":"Bethea","year":"2002","journal-title":"Front Neuroendocrinol"},{"key":"R123-5-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jad.2006.12.011","article-title":"Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model.","volume":"102","author":"Qiao","year":"2007","journal-title":"J Affect Disord"},{"key":"R124-5-20210129","first-page":"296","article-title":"d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.","volume":"76","author":"Brzezinski","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R125-5-20210129","first-page":"1220","article-title":"Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.","volume":"82","author":"Su","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R126-5-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00005-5","article-title":"A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.","volume":"45","author":"Steinberg","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R127-5-20210129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002130100718","article-title":"Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.","volume":"155","author":"Landen","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R128-5-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-0327(94)90059-0","article-title":"B, Coates D C, Fawcett J P. Acute tryptophan depletion aggravates premenstrual syndrome.","volume":"32","author":"Menkes","year":"1994","journal-title":"J Affect Disord"},{"key":"R129-5-20210129","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1176\/appi.ajp.159.11.1876","article-title":"A, Murphy D L, Rubinow D. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.","volume":"159","author":"Roca","year":"2002","journal-title":"J Am Psychiatry"},{"key":"R130-5-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-006-0607-9","article-title":"Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.","volume":"190","author":"Inoue","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"R131-5-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0033291700020407","article-title":"Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change.","volume":"21","author":"Bancroft","year":"1991","journal-title":"Psychol Med"},{"key":"R132-5-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pscychresns.2005.02.012","article-title":"Mood changes correlate to changes in brain serotonin precursor trapping in women with premenstrual dysphoria.","volume":"146","author":"Eriksson","year":"2006","journal-title":"Psychiatry Res"},{"key":"R133-5-20210129","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/ajp.154.4.556","article-title":"Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.","volume":"154","author":"Fitzgerald","year":"1997","journal-title":"J Am Psychiatry"},{"key":"R134-5-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2190\/J2W0-RTGD-NYKK-FF77","article-title":"Altered serotonergic activity in women with dysphoric premenstrual syndromes.","volume":"23","author":"Halbreich","year":"1993","journal-title":"J Int Psychiatry Med"},{"key":"R135-5-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0306-4530(02)00033-1","article-title":"Serotonin transporter gene polymorphisms and platelet 3H paroxetine binding in premenstrual dysphoria.","volume":"28","author":"Melke","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R136-5-20210129","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0015-0282(99)00452-5","article-title":"Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome.","volume":"73","author":"Rasgon","year":"2000","journal-title":"Fertil Steril"},{"key":"R137-5-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000293135","article-title":"Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes.","volume":"31","author":"Rojansky","year":"1991","journal-title":"Gynecol Obstet Invest"},{"key":"R138-5-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9378(11)91653-6","article-title":"F, Stout A L, Knight B S, Nemeroff C B. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome.","volume":"167","author":"Steege","year":"1992","journal-title":"J Am Obstet Gynecol"},{"key":"R139-5-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(99)00062-1","article-title":"Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant.","volume":"87","author":"Steiner","year":"1999","journal-title":"Psychiatry Res"},{"key":"R140-5-20210129","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(89)90149-9","article-title":"Serotonin receptors, buspirone, and premenstrual syndrome.","volume":"1","author":"Yatham","year":"1989","journal-title":"Lancet"},{"key":"R141-5-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pscychresns.2006.05.002","article-title":"A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria.","volume":"148","author":"Jovanovic","year":"2006","journal-title":"Psychiatry Res"},{"key":"R142-5-20210129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.59.9.851","article-title":"Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.","volume":"59","author":"Epperson","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R143-5-20210129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0006-3223(00)01044-1","article-title":"Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.","volume":"49","author":"Girdler","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R144-5-20210129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archpsyc.1993.01820180069007","article-title":"Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.","volume":"50","author":"Schmidt","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"R145-5-20210129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.ajp.161.2.368","article-title":"Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.","volume":"161","author":"Bhagwagar","year":"2004","journal-title":"J Am Psychiatry"},{"key":"R146-5-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0024-3205(91)90027-9","article-title":"Involvement of the GABA Abenzodiazepine chloride ionophore receptor complex in the 5,7-DHT Induced anticonflict effect.","volume":"49","author":"Soderpalm","year":"1991","journal-title":"Life Sci"},{"key":"R147-5-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0306-4530(97)00064-4","article-title":"Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial.","volume":"23","author":"Sundstrom","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"R148-5-20210129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-005-0213-2","article-title":"Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.","volume":"186","author":"Pinna","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R149-5-20210129","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R150-5-20210129","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.biopsych.2007.10.007","article-title":"Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder.","volume":"63","author":"Batra","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R151-5-20210129","first-page":"755","article-title":"Periovulatory beta-endorphin levels in premenstrual syndrome.","volume":"83","author":"Chuong","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R152-5-20210129","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0015-0282(16)49034-5","article-title":"Neuropeptide levels in premenstrual syndrome.","volume":"44","author":"Chuong","year":"1985","journal-title":"Fertil Steril"},{"key":"R153-5-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2190\/JRQJ-XTX9-CQPF-HD70","article-title":"Beta-endorphin decline in late luteal phase dysphoric disorder.","volume":"20","author":"Giannini","year":"1990","journal-title":"J Int Psychiatry Med"},{"key":"R154-5-20210129","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0306-9877(81)90100-6","article-title":"Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression.","volume":"7","author":"Halbreich","year":"1981","journal-title":"Med Hypotheses"},{"key":"R155-5-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9378(81)90417-8","article-title":"Premenstrual syndrome.","volume":"139","author":"Reid","year":"1981","journal-title":"J Am Obstet Gynecol"},{"key":"R156-5-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1037\/0278-6133.21.4.358","article-title":"A, Maixner W, Light K C, Pedersen C A, Costello N L, Girdler S S. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder.","volume":"21","author":"Straneva","year":"2002","journal-title":"Health Psychol"},{"key":"R157-5-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4088\/JCP.v67n0218","article-title":"R, Foris J M, et al. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.","volume":"67","author":"Joffe","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R158-5-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0889-8529(01)00002-0","article-title":"The hypothalamic-pituitary-gonadal axis in mood disorders.","volume":"31","author":"Young E A, Korszun","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R159-5-20210129","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/sj.npp.1301599","article-title":"Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.","volume":"33","author":"Kask","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R160-5-20210129","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.npp.1301351","article-title":"N, Pittman B, Czarkowski K A, Stiklus S, Krystal J H, Grillon C. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.","volume":"32","author":"Epperson","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R161-5-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2007.03.008","article-title":"S, Shen H, Gong Q H, Zhou X. Neurosteroid regulation of GABA(A) receptors: focus on the alpha4 and delta subunits.","volume":"116","author":"Smith","year":"2007","journal-title":"Pharmacol Ther"},{"key":"R162-5-20210129","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0028-3908(02)00171-5","article-title":"Progesterone withdrawal increases the 4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology: a comparison with female rats.","volume":"43","author":"Gulinello","year":"2002","journal-title":"Neuropharmacology"},{"key":"R163-5-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2007.01.031","article-title":"R, Smith M J, Schenkel L A, Schmidt P J, Dancer K. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls.","volume":"104","author":"Rubinow","year":"2007","journal-title":"J Affect Disord"},{"key":"R164-5-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2007.09.015","article-title":"Toward a functional neuroanatomy of premenstrual dysphoric disorder.","volume":"108","author":"Protopopescu","year":"2008","journal-title":"J Affect Disord"},{"key":"R165-5-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.comppsych.2007.02.006","article-title":"C, Liu C Y, Hsiao M C. A comparison of the Tridimensional Personality Questionnaire in premenstrual dysphoric disorder and major depressive disorder.","volume":"48","author":"Hsu","year":"2007","journal-title":"Compr Psychiatry"},{"key":"R166-5-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0002-9378(84)80016-2","article-title":"Premenstrual syndrome: weight, abdominal swelling, and perceived body image.","volume":"150","author":"Faratian","year":"1984","journal-title":"J Am Obstet Gynecol"},{"key":"R167-5-20210129","first-page":"546","article-title":"Body water and weight in patients with premenstrual tension.","volume":"85","author":"Andersch","year":"1978","journal-title":"J Br Obstet Gynaecol"},{"key":"R168-5-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006254-198311000-00001","article-title":"Bromocriptine and premenstrual symptoms: a survey of double blind trials.","volume":"38","author":"Andersch","year":"1983","journal-title":"Obstet Gynecol Surv"},{"key":"R169-5-20210129","first-page":"292","article-title":"Bromocriptine and norethisterone in the treatment of premenstrual syndrome.","volume":"59","author":"Ylostalo","year":"1982","journal-title":"Obstet Gynecol"},{"key":"R170-5-20210129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1078\/094471103322004866","article-title":"Chaste tree (Vitex agnus-castus)pharmacology and clinical indications.","volume":"10","author":"Wuttke","year":"2003","journal-title":"Phytomedicine"},{"key":"R171-5-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9378(99)70142-0","article-title":"Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.","volume":"180","author":"OBrien","year":"1999","journal-title":"J Am Obstet Gynecol"},{"key":"R172-5-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1471-0528.2006.00943.x","article-title":"Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study.","volume":"113","author":"Oksa","year":"2006","journal-title":"BJOG"},{"key":"R173-5-20210129","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1979.tb10582.x","article-title":"Treatment of premenstrual syndrome by spironolactone.","volume":"86","author":"OBrien","year":"1979","journal-title":"J Br Obstet Gynaecol"},{"key":"R174-5-20210129","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/HYPERTENSIONAHA.107.107136","article-title":"Hormonal and volume dysregulation in women with premenstrual syndrome.","volume":"51","author":"Rosenfeld","year":"2008","journal-title":"Hypertension"},{"key":"R175-5-20210129","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1526-4610.2007.00784.x","article-title":"E, Bushnell C D, Herial N A, Utley C, White L, Hafeez F. Endometriosis is associated with prevalence of comorbid conditions in migraine.","volume":"47","author":"Tietjen","year":"2007","journal-title":"Headache"},{"key":"R177-5-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006842-199509000-00006","article-title":"Perimenstrual depression: its relationship to pain, bleeding, and previous history of depression.","volume":"57","author":"Bancroft","year":"1995","journal-title":"Psychosom Med"},{"issue":"suppl 3","key":"R178-5-20210129","first-page":"S5","article-title":"Diagnosis and treatment of premenstrual dysphoric disorder: an update.","volume":"15","author":"Steiner","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"R179-5-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00737-003-0027-3","article-title":"R, Gyulai L, Freeman E W, Morrison M F, Baldassano C, Dube B. Premenstrual dysphoric disorder and psychiatric co-morbidity.","volume":"7","author":"Kim","year":"2004","journal-title":"Arch Womens Ment Health"},{"key":"R180-5-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-0327(90)90126-S","article-title":"B, Frank E, Rivera-Tovar A, Thoft J S, Jacobs E, Mieczkowski T A. Prevalence of AxisII Axis I disorders in women with late luteal phase dysphoric disorder.","volume":"20","author":"Pearlstein","year":"1990","journal-title":"J Affect Disord"},{"key":"R181-5-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0447.1985.tb02532.x","article-title":"Relationship of dysphoric premenstrual changes to depressive disorders.","volume":"71","author":"Halbreich","year":"1985","journal-title":"Acta Psychiatr Scand"},{"key":"R182-5-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00006842-198112000-00008","article-title":"Premenstrual changes and affective disorders.","volume":"43","author":"Endicott","year":"1981","journal-title":"Psychosom Med"},{"key":"R183-5-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-0327(86)90044-3","article-title":"Lifetime prevalence of psychiatric disorders in women with perimenstrual difficulties.","volume":"10","author":"Mackenzie T B, Wilcox","year":"1986","journal-title":"J Affect Disord"},{"key":"R184-5-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0887-6185(92)90004-Q","article-title":"P, Giovanni R, Genazzani A R, Facchinetti F. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder.","volume":"6","author":"Fava","year":"1992","journal-title":"J Anxiety Disord"},{"key":"R185-5-20210129","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v62n0905","article-title":"Mood disorder history and personality assessment in premenstrual dysphoric disorder.","volume":"62","author":"Critchlow","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R186-5-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000012363","article-title":"Personality disorders and depressive symptoms in late luteal phase dysphoric disorder.","volume":"69","author":"De Ronchi","year":"2000","journal-title":"Psychother Psychosom"},{"key":"R187-5-20210129","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1176\/ajp.154.10.1436","article-title":"D, Lam R W, Misri S, et al. Seasonality of symptoms in women with late luteal phase dysphoric disorder.","volume":"154","author":"Maskall","year":"1997","journal-title":"J Am Psychiatry"},{"key":"R188-5-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-0327(00)00176-2","article-title":"Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder.","volume":"63","author":"Praschak-Rieder","year":"2001","journal-title":"J Affect Disord"},{"key":"R189-5-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0447.1990.tb06479.x","article-title":"Premenstrual depression predicts future major depressive disorder.","volume":"81","author":"Graze K K, Nee","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"R190-5-20210129","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/jclp.1119","article-title":"A, Arduino K E, Gehlert S. Premenstrual dysphoric disorder and risk for major depressive disorder: a preliminary study.","volume":"57","author":"Hartlage","year":"2001","journal-title":"J Clin Psychol"},{"key":"R191-5-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1176\/appi.ajp.163.1.133","article-title":"Premenstrual symptoms and perimenopausal depression.","volume":"163","author":"Richards","year":"2006","journal-title":"J Am Psychiatry"},{"key":"R192-5-20210129","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1176\/appi.ajp.157.6.924","article-title":"Effects of gonadal steroids in women with a history of postpartum depression.","volume":"157","author":"Bloch","year":"2000","journal-title":"J Am Psychiatry"},{"key":"R193-5-20210129","first-page":"135","article-title":"Premenstrual exacerbations of mood disorders.","volume":"35","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"R194-5-20210129","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4088\/JCP.v68n1218","article-title":"F, Viguera A C, et al. Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report.","volume":"68","author":"Joffe","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R195-5-20210129","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4088\/JCP.v68n0620","article-title":"T, Silkey B S, Kornstein S G, Clary C M. Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status.","volume":"68","author":"Harvey","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R196-5-20210129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S0033291704004106","article-title":"G, Harvey A T, Rush A J, et al. Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression.","volume":"35","author":"Kornstein","year":"2005","journal-title":"Psychol Med"},{"key":"R197-5-20210129","first-page":"289","article-title":"Premenstrual exacerbation of depression: one process or two.","volume":"53","author":"Yonkers K A, White","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"R198-5-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.jcp.0000229483.52955.ec","article-title":"C, Serra M, Carta M G, Contu P, Pisu M G, Biggio G. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.","volume":"26","author":"Hardoy","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R199-5-20210129","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/01.psy.0000138131.92408.b9","article-title":"A, Brandenburg D L, Kravitz H M. Premenstrual exacerbation of depressive disorders in a community-based sample in the United States.","volume":"66","author":"Hartlage","year":"2004","journal-title":"Psychosom Med"},{"key":"R200-5-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1440-1819.2002.01036.x","article-title":"C, Liu C Y, Chen K C, Hsieh T T. Characteristics of women using a mental health clinic in a gynecologic out-patient setting.","volume":"56","author":"Hsiao","year":"2002","journal-title":"Psychiatry Clin Neurosci"},{"key":"R201-5-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jad.2006.08.013","article-title":"L, Roy P S, Murphy-Eberenz K, et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder.","volume":"99","author":"Payne","year":"2007","journal-title":"J Affect Disord"},{"key":"R202-5-20210129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/da.10089","article-title":"How does premenstrual dysphoric disorder relate to depression and anxiety disorders.","volume":"17","author":"Landen","year":"2003","journal-title":"Depress Anxiety"},{"key":"R203-5-20210129","first-page":"62","article-title":"Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders.","volume":"58","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R204-5-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.yic.0000199454.62423.99","article-title":"C, Denys D, Bus L, Westenberg H G. Female hormones affect symptom severity in obsessive-compulsive disorder.","volume":"21","author":"Vulink","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R205-5-20210129","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/sleep\/30.10.1283","article-title":"C, Kahan T L, Trinder J, Colrain I M. Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome.","volume":"30","author":"Baker","year":"2007","journal-title":"Sleep"},{"key":"R206-5-20210129","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/00023210-200620070-00001","article-title":"M, Eriksson E, Backstrom T, Yonkers K A, Freeman E W. Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndromepremenstrual dysphoric disorder.","volume":"20","author":"Halbreich","year":"2006","journal-title":"CNS Drugs"},{"issue":"4","key":"R207-5-20210129","first-page":"CD001396","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome.","author":"Wyatt","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R209-5-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0893-133X(94)00076-C","article-title":"The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.","volume":"12","author":"Eriksson","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"R210-5-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0301-2115(97)02741-3","article-title":"Fluoxetine in the treatment of premenstrual syndrome.","volume":"73","author":"Ozeren","year":"1997","journal-title":"J Eur Obstet Gynecol Reprod Biol"},{"key":"R211-5-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/bmj.305.6849.346","article-title":"B, Taghavi E, Mason P A, Spears G FS, Howard R C. Fluoxetine treatment of severe premenstrual syndrome.","volume":"305","author":"Menkes","year":"1992","journal-title":"Br J Med"},{"key":"R212-5-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(96)00245-X","article-title":"Fluoxetine in the treatment of premenstrual dysphoria.","volume":"16","author":"Su","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"R213-5-20210129","first-page":"339","article-title":"H, Mortola J F, Chan Y F, Moossazadeh F, Yen S S. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.","volume":"80","author":"Wood","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R214-5-20210129","first-page":"771","article-title":"Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.","volume":"33","author":"Steiner","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"R215-5-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1993.52","article-title":"Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.","volume":"9","author":"Sundblad","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"R216-5-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.1992.tb01440.x","article-title":"Clomipraine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.","volume":"85","author":"Sundblad","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"R217-5-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199810000-00007","article-title":"Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle.","volume":"18","author":"Wikander","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R218-5-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00737-007-0181-0","article-title":"N, Woods S A, Steiner M, Ravindran A V. Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series.","volume":"10","author":"Ravindran","year":"2007","journal-title":"Arch Womens Ment Health"},{"key":"R219-5-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JCP.0b013e3181678a28","article-title":"MD, Ekman A P, Sinclair S MD, et al. Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder.","volume":"28","author":"Eriksson","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R220-5-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-199708000-00004","article-title":"Comparison of fluoxetine, buproprion, and placebo in the treatment of premenstrual dysphoric disorder.","volume":"17","author":"Pearlstein","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"R221-5-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00737-002-0162-2","article-title":"Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.","volume":"6","author":"Steiner","year":"2003","journal-title":"Arch Womens Ment Health"},{"key":"R222-5-20210129","first-page":"290","article-title":"Fluoxetine in the treatment of late luteal phase dysphoric disorder.","volume":"52","author":"Stone","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"R223-5-20210129","first-page":"435","article-title":"Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.","volume":"100","author":"Cohen","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R224-5-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-2918(02)85043-3","article-title":"Weekly luteal phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.","volume":"24","author":"Miner","year":"2002","journal-title":"Clin Ther"},{"key":"R225-5-20210129","first-page":"41","article-title":"A, Halbreich U, Freeman E W, Brown C S, Pearlstein T B. Sertraline in the treatment of premenstrual dysphoric disorder.","volume":"32","author":"Yonkers","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"R226-5-20210129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4088\/JCP.v61n0807","article-title":"Predictors of response to sertraline treatment of severe premenstrual syndromes.","volume":"61","author":"Freeman","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R227-5-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.psy.0000140005.94790.9c","article-title":"Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.","volume":"66","author":"Cohen","year":"2004","journal-title":"Psychosom Med"},{"key":"R228-5-20210129","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajog.2005.01.021","article-title":"Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.","volume":"193","author":"Steiner","year":"2005","journal-title":"J Am Obstet Gynecol"},{"key":"R229-5-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/01.jcp.0000203197.03829.ae","article-title":"Symptom-onset treatment for women with premenstrual dysphoric disorder.","volume":"26","author":"Yonkers","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R230-5-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.npp.1301216","article-title":"Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.","volume":"32","author":"Landen","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R231-5-20210129","first-page":"737","article-title":"Venlafaxine in the treatment of premenstrual dysphoric disorder.","volume":"98","author":"Freeman","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R232-5-20210129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.jcp.0000138767.53976.10","article-title":"Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.","volume":"24","author":"Cohen","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R233-5-20210129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.161.2.343","article-title":"Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.","volume":"161","author":"Freeman","year":"2004","journal-title":"J Am Psychiatry"},{"key":"R234-5-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s007370200009","article-title":"New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder.","volume":"4","author":"Eriksson","year":"2002","journal-title":"Arch Womens Ment Health"},{"key":"R235-5-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jwh.2006.15.57","article-title":"Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.","volume":"15","author":"Steiner","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"R236-5-20210129","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.56.10.932","article-title":"Differential response to antidepressants in women with premenstrual syndromepremenstrual dysphonic disorder: a randomised controlled trial.","volume":"56","author":"Freeman","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R237-5-20210129","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1517\/14656566.4.11.2065","article-title":"Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.","volume":"4","author":"Halbreich","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"R238-5-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archfami.8.4.328","article-title":"Luteal phase sertraline treatment for premenstrual dysphoric disorder: results of a double-blind, placebo-controlled, crossover study.","volume":"8","author":"Jermain","year":"1999","journal-title":"Arch Fam Med"},{"key":"R239-5-20210129","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4088\/JCP.v59n0206","article-title":"Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomised, double-blind, placebo controlled crossover trial.","volume":"59","author":"Young","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R240-5-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2004.10.006","article-title":"A, Pearlstein T, Fayyad R, Gillespie J A. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.","volume":"85","author":"Yonkers","year":"2005","journal-title":"J Affect Disord"},{"key":"R241-5-20210129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4088\/JCP.v58n0905","article-title":"W. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.","volume":"58","author":"Halbreich","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R242-5-20210129","first-page":"1219","article-title":"Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.","volume":"100","author":"Halbreich","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R243-5-20210129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4088\/JCP.v66n0616","article-title":"W, Sondheimer S J, Sammel M D, Ferdousi T, Lin H. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.","volume":"66","author":"Freeman","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R244-5-20210129","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.4088\/JCP.v67n1020","article-title":"G, Pearlstein T B, Fayyad R, Farfel G M, Gillespie J A. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.","volume":"67","author":"Kornstein","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R245-5-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0924-977X(97)00404-5","article-title":"A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side effects during ten cycles of treatment.","volume":"7","author":"Sundblad","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"R246-5-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1192\/bjp.176.4.363","article-title":"Interruption of selective serotonin reuptake inhibitor treatment: double-blind placebo-controlled trial.","volume":"176","author":"Michelson","year":"2000","journal-title":"J Br Psychiatry"},{"key":"R247-5-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-3223(98)00126-7","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.","volume":"44","author":"Rosenbaum","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R248-5-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004850-200209000-00002","article-title":"Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.","volume":"17","author":"Judge","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"R249-5-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0447.1980.tb00569.x","article-title":"Treatment of premenstrual tension with lithium carbonate. A pilot study.","volume":"61","author":"Steiner","year":"1980","journal-title":"Acta Psychiatr Scand"},{"key":"R250-5-20210129","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.56.10.932","article-title":"W, Rickels K, Sondheimer S J, Polansky M. Differential response to antidepressants in women with premenstrual syndromepremenstrual dysphoric disorder: a randomized controlled trial.","volume":"56","author":"Freeman","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R251-5-20210129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(89)92591-9","article-title":"Buspirone in treatment of premenstrual syndrome.","volume":"4","author":"Rickels","year":"1989","journal-title":"Lancet"},{"key":"R252-5-20210129","first-page":"37","article-title":"Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.","volume":"70","author":"Smith","year":"1987","journal-title":"Obstet Gynecol"},{"key":"R253-5-20210129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.1990.01810150070011","article-title":"Treatment of premenstrual dysphoria with alprazolam.","volume":"47","author":"Harrison","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R254-5-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1995.03530010065036","article-title":"A double-blind trail of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.","volume":"274","author":"Freeman","year":"1995","journal-title":"JAMA"},{"key":"R255-5-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bpobgyn.2007.07.001","article-title":"Hormonal management of premenstrual syndrome.","volume":"22","author":"Usman","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R256-5-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0306-4530(90)90072-H","article-title":"Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS).","volume":"15","author":"Dhar","year":"1990","journal-title":"Psychoneuroendocrinology"},{"key":"R257-5-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09513599909167531","article-title":"The treatment of severe premenstrual syndrome with goserelin with and without add-back estrogen therapy: a placebo-controlled study.","volume":"13","author":"Leather","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"R258-5-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0015-0282(00)01707-6","article-title":"Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.","volume":"75","author":"Di Carlo","year":"2001","journal-title":"Fertil Steril"},{"key":"R259-5-20210129","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0015-0282(16)54718-9","article-title":"Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes.","volume":"56","author":"Halbreich","year":"1991","journal-title":"Fertil Steril"},{"key":"R260-5-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/pgmj.67.787.450","article-title":"Low dose danazol in the treatment of the premenstrual syndrome.","volume":"67","author":"Deeny","year":"1991","journal-title":"Postgrad J Med"},{"key":"R261-5-20210129","first-page":"33","article-title":"Premenstrual syndrome: beneficial effects of periodic, low-dose danazol.","volume":"70","author":"Sarno","year":"1987","journal-title":"Obstet Gynecol"},{"key":"R262-5-20210129","first-page":"87","article-title":"Danazol and premenstrual syndrome.","volume":"55","author":"Day","year":"1979","journal-title":"Postgrad J Med"},{"key":"R263-5-20210129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1471-0528.1987.tb02248.x","article-title":"A clinical trial using danazol for the treatment of premenstrual tension.","volume":"94","author":"Watts","year":"1987","journal-title":"J Br Obstet Gynaecol"},{"key":"R264-5-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-4530(94)00053-D","article-title":"M, Van Vugt D A, Reid R L. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome.","volume":"20","author":"Hahn","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"R265-5-20210129","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/bmj.292.6536.1629","article-title":"Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo-controlled study.","volume":"292","author":"Magos","year":"1986","journal-title":"Br J Med (Clin Res Ed)"},{"key":"R266-5-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/09513599009012326","article-title":"R, Studd J W, Savvas M, Baber R J. The long-term effects of estradiol implant therapy for the treatment of premenstrual syndrome.","volume":"4","author":"Watson","year":"1990","journal-title":"Gynecol Endocrinol"},{"key":"R267-5-20210129","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(89)90784-8","article-title":"Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.","volume":"2","author":"Watson","year":"1989","journal-title":"Lancet"},{"issue":"suppl 3","key":"R268-5-20210129","first-page":"37","article-title":"Treatment of premenstrual syndrome with transdermal oestrogen.","volume":"83","author":"Domoney","year":"2003","journal-title":"J Int Gynaecol Obstet"},{"key":"R269-5-20210129","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mob.2003.346","article-title":"Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system.","volume":"188","author":"Wildemeersch","year":"2003","journal-title":"J Am Obstet Gynecol"},{"key":"R270-5-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-3999(93)90086-U","article-title":"The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.","volume":"37","author":"Bancroft","year":"1993","journal-title":"J Psychosom Res"},{"key":"R271-5-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.","volume":"36","year":"1992","journal-title":"J Psychosom Res"},{"key":"R272-5-20210129","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users.","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R273-5-20210129","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms.","volume":"186","author":"Sulak","year":"2002","journal-title":"J Am Obstet Gynecol"},{"issue":"suppl 3","key":"R274-5-20210129","first-page":"27","article-title":"Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.","volume":"7","year":"2002","journal-title":"J Eur Contracept Reprod Health Care"},{"key":"R276-5-20210129","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1517\/14656566.8.7.989","article-title":"Drospirenone: a novel progestin.","volume":"8","year":"2007","journal-title":"Exp Opin Pharmacother"},{"key":"R277-5-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R278-5-20210129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"R279-5-20210129","first-page":"49","article-title":"Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.","volume":"6","author":"Rubig","year":"2003","journal-title":"Climateric"},{"key":"R280-5-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4530(92)90058-F","article-title":"Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls.","volume":"17","author":"Eriksson","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"R281-5-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ajog.2005.01.055","article-title":"M, Guyatt G H, Heels-Ansdell D, Busse J W. The effect of bright light therapy on depression associated with premenstrual dysphoric disorder.","volume":"193","author":"Krasnik","year":"2005","journal-title":"J Am Obstet Gynecol"},{"key":"R282-5-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-1781(99)00043-8","article-title":"W, Carter D, Misri S, Kuan A J, Yatham L N, Zis A P. A controlled study of light therapy in women with late luteal phase dysphoric disorder.","volume":"86","author":"Lam","year":"1999","journal-title":"Psychiatry Res"},{"key":"R283-5-20210129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1176\/ajp.146.9.1215","article-title":"L, Berga S L, Mostofi N, Sependa P A, Kripke D F, Gillin J C. Morning versus evening bright light treatment of late luteal phase dysphoric disorder.","volume":"146","author":"Parry","year":"1989","journal-title":"J Am Psychiatry"},{"key":"R284-5-20210129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1185\/03007998709112403","article-title":"A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.","volume":"10","author":"Vellacott","year":"1987","journal-title":"Curr Med Res Opin"},{"key":"RU285-5-20210129","first-page":"120","article-title":"Spironolactone in the treatment of premenstrual tension: a double-blind study of spironolactone vs. bendroflumethiazide and placebo.","volume":"49","author":"Aslaksen","year":"1991","journal-title":"Curr Ther Res Clin Exp"},{"key":"R286-5-20210129","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R287-5-20210129","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","article-title":"M, Dimmock P W, Jones P W, Shaughn OBrien P M. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review.","volume":"318","author":"Wyatt","year":"1999","journal-title":"BMJ"},{"key":"R288-5-20210129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/07315724.1991.10718176","article-title":"Effect of nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study.","volume":"10","author":"London","year":"1991","journal-title":"J Am Coll Nutr"},{"key":"R289-5-20210129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/07315724.2000.10718920","article-title":"Micronutrients and the premenstrual syndrome: the case for calcium.","volume":"19","author":"Thys-Jacobs","year":"2000","journal-title":"J Am Coll Nutr"},{"key":"R290-5-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02599520","article-title":"Calcium supplementation in premenstrual syndrome: a randomized crossover trial.","volume":"4","author":"Thys-Jacobs","year":"1989","journal-title":"J Gen Intern Med"},{"key":"R291-5-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"J Am Obstet Gynecol"},{"key":"R292-5-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/jwh.1998.7.1157","article-title":"F, De Souza M C, Vickers M F, Abeyasekera S, Collins M L, Trinca L A. Magnesium supplementation alleviates premenstrual symptoms of fluid retention.","volume":"7","author":"Walker","year":"1998","journal-title":"J Womens Health"},{"key":"R293-5-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biopsych.2005.07.022","article-title":"L, Elin R J, Niemela J E, Schmidt P J, Rubinow D R. Magnesium (Mg) retention and mood effects after intravenous Mg infusion in premenstrual dysphoric disorder.","volume":"59","author":"Khine","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R294-5-20210129","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.322.7279.134","article-title":"Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study.","volume":"322","author":"Schellenberg","year":"2001","journal-title":"BMJ"},{"key":"R295-5-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s004040000123","article-title":"Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).","volume":"264","author":"Berger","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"R296-5-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hup.470","article-title":"Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.","volume":"18","author":"Atmaca","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"R297-5-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/152460900318515","article-title":"Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus.","volume":"9","author":"Loch E G, Selle","year":"2000","journal-title":"J Womens Health Gend Based Med"},{"key":"R298-5-20210129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0197-2456(95)00082-8","article-title":"Is evening primrose oil of value in the treatment of premenstrual syndrome.","volume":"17","author":"Budeiri","year":"1996","journal-title":"Control Clin Trials"},{"key":"R300-5-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1471-0528.2000.tb11085.x","article-title":"A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome.","volume":"107","author":"Stevinson","year":"2000","journal-title":"BJOG"},{"key":"R301-5-20210129","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2105\/AJPH.80.9.1106","article-title":"Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome.","volume":"80","author":"Rossignol A M, Bonnlander","year":"1990","journal-title":"J Am Public Health"},{"key":"R302-5-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0029-7844(95)00246-N","article-title":"The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome.","volume":"86","author":"Sayegh","year":"1995","journal-title":"Obstet Gynecol"},{"key":"R303-5-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0020-7292(02)00033-4","article-title":"Treatment of premenstrual syndrome with a carbohydrate-rich beverage.","volume":"77","author":"Freeman","year":"2002","journal-title":"J Int Gynecol Obstet"},{"key":"R304-5-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0022-3999(93)90079-U","article-title":"The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study.","volume":"37","author":"Steege","year":"1993","journal-title":"J Psychosom Res"},{"key":"R305-5-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/01674820209074672","article-title":"A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder.","volume":"23","author":"Hunter","year":"2002","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"R306-5-20210129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0022-3999(02)00338-0","article-title":"S, Ussher J M, Cariss M, Browne S, Jelley R, Katz M. Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes.","volume":"53","author":"Hunter","year":"2002","journal-title":"J Psychosom Res"},{"key":"R307-5-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3999(98)00042-7","article-title":"Cognitive therapy for premenstrual syndrome: a controlled trial.","volume":"45","author":"Blake","year":"1998","journal-title":"J Psychosom Res"},{"key":"R308-5-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-0327(94)00073-I","article-title":"The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes.","volume":"33","year":"1995","journal-title":"J Affect Disord"},{"key":"R309-5-20210129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00006250-198609000-00022","article-title":"Mefenamic acid in the treatment of premenstrual syndrome.","volume":"68","author":"Mira","year":"1986","journal-title":"Obstet Gynecol"},{"key":"R310-5-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000293579","article-title":"Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study.","volume":"28","author":"Facchinetti","year":"1989","journal-title":"Gynecol Obstet Invest"},{"key":"R311-5-20210129","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0015-0282(16)56753-3","article-title":"Effect of naloxone on luteinizing hormone secretion in premenstrual syndrome.","volume":"61","author":"Chuong","year":"1994","journal-title":"Fertil Steril"},{"key":"R312-5-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0193-953X(05)70007-1","article-title":"Psychoneuroendocrinology of depression. Hypothalamic pituitary-gonadal axis.","volume":"21","author":"Young","year":"1998","journal-title":"Psychiatr Clin North Am"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00023727-200904000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:47Z","timestamp":1786038527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00023727-200904000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":304,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1080\/10673220902891836","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}